The Cancer Center Support Grant (CCSG) Developmental Funds Award (DFA) is funded through the Lombardi’s CCSG, which is funded by the NIH. The purpose of the Award is to encourage synergy among investigators, both within and across programs, and to foster new collaborations.
The grant is available to all faculty members and is not limited to junior faculty. The CCSG Award provides $30,000 per team to three “teams” of researchers. Each of the awards is for one year only, and is not renewable. Priority will be given to projects that have a high likelihood for future funding.
Successful proposals will have at least two faculty members making substantial contributions to the project and be from clearly different disciplines, preferably different programs. If one of the faculty members is providing a service, for example something that would be available in a shared resource, then this may not be considered a synergy award.
John Casey, PhD, Ruth He, MD, PhD, and Xuefeng Liu, MD Long-Term Culture of Human Hepatocytes for Viral Hepatitis Research
Chris Loffredo, PhD, Kirti Shetty, MD, and Brent Korba, PhD HCV Mutations and Risk of Subsequent Liver Cancer in Patients with Chronic Liver Disease
Jeanne Mandelblatt, MD, PhD, and John Van Meter, PhD Neuroimaging of Cognitive Changes in Older Breast Cancer Patients
Ronit Yarden, PhD, and Michael Johnson, PhD The Role of BRCA1 Ubiquitin E3 Ligase Novel Function in Chemoresistance
Johanna Kitlinska, PhD Cortisol, Neuronal Differentiation and Neuroblastoma Development: Is There a Link?
2010/2011
Aykut Uren, MD Development of Small Molecule Inhibitors for ERG and ETV1 Transcriptive Factors
John Deeken, MD, Kristi Graves, PhD, Arnold Potosky, MHS, PhD Personalized Medicine through Pharmacogenetics in Treatment of Gastrointestinal Cancer
Ryan McAllister, PhD Primary Cells in 3D Biomechanics Assay: Motility, Force Generation, and Proteolysis
Anna Riegel, PhD Development of New Models of Early Stage Breast Cancer
Rabindra Roy, PhD, and Siva Dakshanamurthy, PhD Inhibitors of Human-N-Methylpurine-CNA Glycosylase and Chemosensitization of Glioblastomas
Yun-Ling Zheng, PhD, MPH, and Xuefeng Liu, MD Role of Non-Telomeric and Telomeric Activities of Telomerase in Cell Immortilization and Malignant Transformation
2009/2010
Christopher Albanese, PhD, Aykut Üren, MD, Milton L. Brown, Md, PhD, Jeffrey Toretsky, MD, & Bahram Moasser, PhD Effects of Arsenic Trioxide or VMY-1-103, a GUMC CDK Inhibitor, on Medulloblastoma Proliferation and Apoptosis In Vitro and In Vivo
Yali Kong, PhD & Brent Korba, PhD Development of Small Molecule Inhibitors for Hepatitis C Virus
Mary Beth Martin, PhD, Jennifer Eng-Wong, MD, & Celia Byrne, PhD Role of Metalloestrogens in Breast Cancer
2008/2009
Robert Glazer, PhD, Stephen ByersPhD, & M. Blair Marshall, MD Tumor Stem Cell Signaling in Primary Non-Small Cell Lung Cancer (NSCLC)
Ian Gallicano, PhD, Partha Banerjee, PhD, & Christopher Albanese, PhD Narrowing the Definition of the Prostate Cancer Stem Cell
Celia Byrne, PhD, & Bassem Haddad, MD Role of NOS in Breast Cancer: A Feasibility Study
2006/2007
Yun-Ling Zheng, PhD Telomere Dysfunction and Breast Cancer Risk
2005/2006
Christopher Albanese, PhD Development of Negative and Positive MR Contrast Agent for Cancer Imaging
Radoslav Goldman, PhD Isotope Dilution of Peptides for Early Detection of Liver Cancer
Offie Soldin, PhD, MBA Urban Environmental Pesticides and Childhood Cancer
Aykut Üren, MD Peptide Inhibitors of Ewing Sarcoma Oncoprotein EWS/FLI1
2004/2005
Kevin FitzGerald, PhD Functional Characterization of MLL2, a Novel Trithorax Protein
Peter Lebowitz, MD, PhD Role of PTEN-Regulated Pathways in Breast Cancer Chemosensitivity and Prognosis
Andrew Quong, PhD Microcantilever-Based Assays of Protein Expression in Breast Cancer
Offie Soldin, PhD, MBA Urban Environmental Pesticides and Childhood Cancer
Yun-Ling Zheng, PhD Telomere Dysfunction and Breast Cancer Risk
How to Apply
The CCSG Development Funds Awards (DFA) are designed to provide seed money for critical grants in the areas of investigator-initiated studies, synergy awards and research targeted to developing new technologies. The DFAs are funded by the National Cancer institute through Georgetown Lombardi’s Core Grant.
General rules, requirements and application can be found on LombardiNet*
